GlassScriptPhysician profile
Maxx A Gallegos
NPI 1689966145
$4,708.37
in general payments reported to CMS, 2019-2025
22 companies · $899 in 2025
The $899 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $285 · 2021: $172 · 2022: $587 · 2023: $1,624 · 2024: $805 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,328.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,652.07 | 2019-2024 | Ams 700, Advance Xp, Ams 800 Artificial Urinary Sphincter |
| Coloplast Corp | $1,301.75 | 2019-2025 | Titan, Virtue |
| Musculoskeletal Transplant Foundation INC. | $318.10 | 2025 | |
| Karl Storz Endoscopy-America | $317.18 | 2020-2023 | Flex-X |
| Olympus America INC. | $137.74 | 2025 | Uretero-Reno Videoscope |
| Laborie Medical Technologies Corp. | $125.00 | 2023 | |
| Innovation Technologies INC | $123.38 | 2024 | Irrisept |
| Photocure INC | $114.04 | 2022-2023 | Cysview |
| Motiva USA, LLC | $108.71 | 2025 | |
| Merck Sharp & Dohme LLC | $87.10 | 2021 | |
| Neotract INC. | $82.25 | 2020 | |
| Abbvie INC. | $62.29 | 2025 | |
| Urogen Pharma, INC. | $55.26 | 2022 | |
| Depuy Synthes Sales INC. | $42.58 | 2025 | Na |
| Endo Pharmaceuticals INC. | $35.86 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $28.82 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mentor Worldwide LLC | $26.29 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Mimedx Group, INC. | $20.39 | 2025 | |
| Astellas Pharma US INC | $18.95 | 2023 | Myrbetriq |
| Medtronic, INC. | $17.14 | 2025 | V-Loc 180 |
| Solventum Corporation | $16.83 | 2025 | V.A.C.Ulta |
| Ambu INC. | $16.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxx Gallegos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.